Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Data sheet for Lariam updated

Aug. 27, 1997

RespiGam approved for marketing in Canada

Aug. 25, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Chlorhexidine solution prevents perinatal infections

Aug. 22, 1997

GT35 described in patent literature by Kyowa Hakko

Aug. 20, 1997

Positive phase III results for Lidakol in oral herpes

Aug. 19, 1997

U.S. patent issued for Candida albicans treatment method

Aug. 18, 1997

Teva's problems with clindamycin

Aug. 13, 1997

AmBisome cleared by FDA

Aug. 13, 1997

Settlement reached in NeXstar and The Liposome Company patent litigation

Aug. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.